ArticleAdvances in therapy2018

Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis.

Neil M Schultz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.